Biotech Business Week articles from October 2003

Biotech Business Week archives from October 2003

Engineered antibodies may expedite development of therapeutic oncology agents.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Panacea Pharmaceuticals, Inc., has extended and expanded its collaborative research agreement with researchers at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, covering...

Positive phase III results for bicifadine, a novel, non-narcotic analgesic, announced.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- DOV Pharmaceutical, Inc., (DOVP) announced positive efficacy and safety results for its phase III clinical trial investigating its novel, non-narcotic analgesic, bicifadine, in the treatment of moderate...

Patient enrollment completed in cryoblation study.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- CryoCor, Inc., a development stage medical technology company, announced the completion of U.S. patient enrollment of the first phase of the feasibility trial for paroxysmal atrial fibrillation and the...

Merck enters alliance to apply RNA interference for human therapeutics.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Merck & Co., Inc., (MRK) and Alnylam Holding Co., an RNA interference (RNAi) company, announced that they have entered into a multiyear collaboration to develop RNAi-based technology and therapeutics....

Report: Lack of IPOs stifle early-stage healthcare investments.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- The lack of an IPO market isn't just putting pressure on later-stage healthcare companies. Early-stage ventures are suffering too, according to a report in the September issue of The Venture...

Myozyme development program expanded.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Genzyme Corp. (GENZ) announced the launch of several initiatives designed to support the rapid development and approval of Myozyme recombinant human acid alpha-glucosidase and provide greater access to...

Promising results reported on new protease activated therapy.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Dendreon Corporation (DNDN) announced that it will present data on a lead compound from its new Protease Activated Therapy (PACT) therapeutic platform. In preclinical testing to date, the compound,...

Incyte enters licensing agreement for a phase II HIV drug.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Incyte Corp. (INCY) and Pharmasset, Ltd., announced that they have entered into a collaborative licensing agreement to develop and commercialize the antiretroviral drug Reverset, also known as RVT,...

FDA clears BLU-U Blue Light Photodynamic Therapy Illuminator.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- DUSA Pharmaceuticals, Inc., (DUSA) reported that on September 9, 2003, it received 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) for the BLU-U Blue Light Photodynamic...

Innovative Medical enters partnership to develop, market Axenohl-based products.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Innovative Medical Services (PURE) has signed an agreement with Therapeutics, Inc., a drug development company based in La Jolla, California, for the development and commercialization of U.S. Food and...

Amelioration of asthma symptoms reported with anti-C5 therapy.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Alexion Pharmaceuticals, Inc., (ALXN) is reporting that anti-C5 monoclonal antibody therapy blocked the development of bronchial inflammation and reduced airway hyperresponsiveness in preclinical models...

Asthma attacks at school are disruptive to routine, under-diagnosed.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- According to a national sample of members surveyed from the National Association of School Nurses, asthma is more disruptive of school routines than any other chronic condition and has a significant...

NIAID grant to awarded to develop phenotype microarray technology.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Biolog, Inc., announced that it has received a multi-year grant of $2.28 million from the National Institute of Allergy and Infectious Diseases (NIAID). This grant will fund additional development...

Study findings suggest strategy for regeneration of tissues in damaged brains.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Curis, Inc., (CRIS) announced that the current issue of the scientific journal Neuron contains a report demonstrating that the Hedgehog signaling pathway is required for the formation and maintenance of...

GeneMax Corp. announces agreement for the production of TAP cancer vaccine.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- GeneMax Corp. (GMXX) announced an amended contractual agreement with Molecular Medicine BioServices, Inc., of San Diego, California, for the production of its clinical vector for delivery of the TAP...

Epimmune earns milestone payment under cancer epitope license.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Epimmune, Inc., (EPMN) announced that it has earned and received a milestone payment from Anosys, Inc., as a result of Anosys' filing of an IND for a product incorporating Epimmune technology under a...

FDA grants approval to start atrial fibrillation study.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- CryoCath Technologies, Inc., (CYT), announced that is has received Investigational Device Exemption (IDE) conditional approval from the U.S. Food and Drug Administration (FDA) to initiate a study to...

Clinical update provided on BST-CarGel.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- BioSyntech (BSYI) recently announced the treatment of its chairman, Serge Savard with BST-CarGel, under Health Canada's Special Access Programme for medical devices. Savard has fully recovered and...

Research aims to understand how mistakes in DNA replication lead to disease.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Studies at the University of Houston (UH) are shedding light on the mechanisms our bodies use to recognize and repair mistakes in our genetic code, mistakes that, left unchecked, could lead to cancer....

Continuous labor support offers benefits to mothers, babies.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- A new comprehensive study describing the experiences of nearly 13,000 women has found that women who receive supportive care from a companion throughout labor are more likely than women without such...

Agreements signed for cardiac safety monitoring, information distribution services.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- eResearchTechnology, Inc., (eRT, ERES), a provider of centralized electrocardiographic (ECG) collection and interpretation services, announced that it has received agreements for more than $1.4 million...

Alliance with CryoVascular Systems for cardiology device technology.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corporation (BSX) announced that it has entered into a series of agreements with CryoVascular Systems, Inc., a privately held company located in Los Gatos, California. ...

Oral drug delivery research alliance signed.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Access Pharmaceuticals, Inc., (AKC) has entered into a research collaboration in oral drug delivery with the Celltech Group plc (CLL, CCH), of Slough, England. The goal of the collaboration is to...

Generic version of Paxil launched.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Apotex Corp. announced that it has launched paroxetine hydrochloride tablets, 10 mg, 20 mg, 30 mg, and 40 mg. The U.S. Food and Drug Administration has determined that Apotex' paroxetine tablets...

Trial shows Probactrix is effective for treating diarrhea caused by antibiotics.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- The BioBalance Corp., a wholly owned subsidiary of New York Health Care (BBAL), released the results of a randomized clinical study in which a formulation containing its proprietary biotherapeutic...

Mexican distributor granted exclusive rights for Microcyn 60.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Oculus Technologies of Mexico, S.A., de C.V., a subsidiary of Oculus Innovative Sciences, announced the finalization of an exclusive agreement with Quimica Pasteur, S. De RL., for distribution of...

AERx pain management system study data published.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Researchers, led by scientists at Aradigm Corporation, (ARDM) published results of a clinical study involving the AERx Pain Management System in the September 2003 issue of the journal Anesthesiology....

$2M grant awarded for development of drug research software.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Targacept, Inc., has been awarded a grant from the National Institute of Standards and Technology (NIST) through its Advanced Technology Program (ATP) that will provide approximately $2 million over a...

New information management system available for pharma, biotech firms.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Accelrys, a wholly owned subsidiary of Pharmacopeia, Inc., (PCOP), announced the release of its latest solutions for chemical and biological information management: Accord Enterprise Informatics and DS...

Device company gets NIH grant for neurological surgery technology.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Astro-Med, Inc., (ALOT) announced that it has received an SBIR research grant of $107,000 from the U.S. National Institutes of Health for the purpose of developing a computer controlled switching...

Acquisition of pharmaceutical company completed.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Ampersand Ventures, a venture capital firm with approximately $600 million under management in four target sectors, including life sciences, announced that ArQule, Inc., has completed its acquisition of...

American Stock Exchange lists oncology company's stock.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- The American Stock Exchange (AMEX) listed the common stock of Bioenvision, Inc., under the ticker symbol BIV. Bioenvision primarily focuses on the acquisition, development, and distribution of...

Angiotech to change fiscal year end financials to calendar year.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Angiotech Pharmaceuticals, Inc., (ANPI; ANP) announced that it intends to change its fiscal year end from September 30 to December 31, effective as of December 31, 2003. This step is being taken to...

Dialysis company calls 7% convertible notes, authorizes share repurchase.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- DaVita, Inc., (DVA) announced that it is calling for redemption the remainder of its 7% convertible subordinated notes due 2009. The aggregate principal amount outstanding of the Notes is $145...

Medical device company raises $13.6M in second round financing.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- AngioLink Corporation announced that it has raised $13.6 million in preferred equity financing from new and existing investors. JHK Investments, LLC, BioVentures Investors, and IDP Investments led...

Pharmaceutical company's stock listed on AMEX.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- The American Stock Exchange (AMEX) listed the common stock of Pro-Pharmaceuticals, Inc. (PRW). Pro-Pharmaceuticals, Inc., is a drug development company commercializing a new generation of...

Revised financial expectations reported by pharmaceutical company.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Alpharma, Inc., (ALO), a leading global specialty pharmaceutical company, announced revised expectations for the second half and full year 2003. The company currently expects third quarter 2003...

Skin substitute manufacturer emerges from Chapter 11 protection.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Organogenesis Inc. announced the completion of its court-approved reorganization plan, allowing the company to emerge from Chapter 11 protection and continue manufacturing and supplying Apligraf, its...

Topical drug company announces $3.25 million private placement.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- MacroChem Corp. (MCHM) announced that it has raised approximately $3.25 million in gross proceeds from a private placement of its securities, primarily to institutional investors. MacroChem is a...

Venture financing round completed with Emerging Technology Partners.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Adenosine Therapeutics, LLC, announced the completion of a round of venture financing with the Emerging Technology Partners of Rockville, Maryland. In the transaction, the company also acquired...

$4M financing advances antithrombotic agent into clinical development.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Targeted Molecules Corp. (TMC) announced the completion of a $4 million financing by a group of investors that will be used to advance TMC's lead compound, TMC-2001, into clinical development and to...

$6M in funds helps biotech company develop psychiatric disease treatments.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Psychiatric Genomics, Inc., a company utilizing expression analysis of human tissues to develop innovative small molecule drugs to treat mental health disorders, announced closing on a $6 million...

GSK makes announcement regarding launch of generic paroxetine hydrochloride.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- GlaxoSmithKline (GSK) confirmed that a generic form of paroxetine hydrochloride was launched by Apotex Corp. on September 8, 2003, triggering GSK's license agreement with Par Pharmaceutical, Inc. ...

New bioconsumable kits aid in genetic variation discovery and detection.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Transgenomic Inc. (TBIO) has launched the Surveyor line of bioconsumable kits for use in genetic variation discovery and detection, extending the capabilities of the company's Wave system instrument...

HIV-1 antibody tests approved for distribution in the Republic of Uganda.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Calypte Biomedical Corporation (CYPT), the developer and marketer of the only two U.S. Food and Drug Administration (FDA) approved HIV-1 antibody tests that can be used on urine samples, as well as an...

Genetically enhanced bacteria may prevent HIV infections in women.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Researchers at the Stanford University School of Medicine have found in laboratory experiments that bacteria that naturally live in the body can be genetically enhanced for potent antiviral activity,...

Japanese government expands use of automated external defibrillators.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Cardiac Science, Inc., (DFIB) announced that the Japanese Ministry of Health, Labor, and Welfare (MHLW) has for the first time approved the use of automated external defibrillators (AEDs) by non-medical...

Acetaminophen may be best for patients on cardioprotective aspirin therapy.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Heart specialists say acetaminophen, the medicine in Tylenol, may be the best choice over-the-counter pain reliever for the millions of Americans taking aspirin to protect against cardiovascular...

FDA clearance granted for new D-10 Hemoglobin testing system.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Bio-Rad Laboratories, Inc., (BIO; BIO.B) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its D-10 Hemoglobin A1c system that includes both the D-10 instrument and...

Agreement signed with Baxter for Advate distribution.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Curative Health Services, Inc., (CURE) announced that it has signed a multiyear supply agreement with Baxter Healthcare Corporation for Advate (Antihemophilic Factor (Recombinant), Plasma/Albumin-Free...

U.S. commercial availability of Advate announced.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Following its recent U.S. launch of Advate, Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method, (rAHF-PFM), Baxter Healthcare Corporation (BAX) announced that it has signed non-exclusive...

Clinical trials of Coagulin-B to resume.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Avigen, Inc., (AVGN) announced that it has received approval to proceed with its phase I clinical trial of Coagulin-B for the treatment of hemophilia B from both the U.S. Food and Drug Administration...

Hepatitis vaccine approved for sale in Argentina.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Corixa Corporation (CRXA) announced the Argentinean approval of Supervax, Berna Biotech's prophylactic vaccine containing Corixa's synthetic RC-529 adjuvant, for the prevention of Hepatitis B infection....

Final FDA approval received for generic Glucotrol XL 5mg tablets.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Amarin Corporation plc (AMRN) confirmed that Watson Pharmaceuticals, Inc., (WPI), had received approval on its Abbreviated New Drug Application (ANDA) for 5 mg glipizide extended-release tablets from...

New drug application submitted for cinacalcet HCl.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Amgen (AMGN) filed a new drug application (NDA) with the U.S. Food & Drug Administration for cinacalcet HCl, a first-in-class oral calcimimetic agent, licensed from NPS Pharmaceuticals, Inc., currently...

Benicar HCT now available in U.S.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Sankyo Pharma, Inc., and Forest Laboratories, Inc., (FRX) announced that Benicar HCT (olmesartan medoxomil-hydrochlorothiazide) is now available via prescription in the United States. Benicar HCT...

Changes in IV formula can reverse neurological problems in bowel failure patients.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Intravenous feedings may do well to provide patients with small bowel failure their required daily nutrition, but its long-term use can cause their liver to fail and Parkinson-like neurological...

Corixa Corp. signs research, development, and license agreement.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- InNexus Biotechnology, Inc., (IXS), a monoclonal antibody-development company, and Corixa Corp. (CRXA), a developer of immunotherapeutic products, announced that the companies have entered into an...

Adults with asthma fail to follow flu vaccine guidelines.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Adults with asthma are considered a high risk group for developing complications after contracting the influenza virus, yet the majority of adults with asthma does not receive an annual influenza...

Alliance to bring added automation to Oracle clinical users.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- BioPharm Systems, Inc., announced a partnership with Quovadx (QVDX) to introduce a new software and services offering that enhances the communications capabilities and automates key functions of Oracle...

Diabetes care moves online.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- ConnectiCare and Medem announced the launch of a new service that will, for the first time, allow insured patients with diabetes to send their glucose readings to their own doctors securely via the...

Collaborative effort to develop inhaled insulin.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Bristol-Myers Squibb Company (BMY) and QDose, a joint venture between MicroDose Technologies, Inc., and Quadrant Drug Delivery, Ltd., announced that the companies have entered into a licensing agreement...

NIH provides grant for oral insulin development.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- BioSante Pharmaceuticals, Inc., (BISP) announced that it has been awarded a $100,000 Small Business Innovation Research (SBIR) grant from the U.S. National Institutes of Health (NIH) to support the...

Label language finalized for Sucanon release in Mexico.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Robert Rieveley, president of Biotech Holdings (BIOHF.OB; BIO.V), reported that the finalized language for the Sucanon label has been submitted to Mexican regulators. "In the process of finalizing...

Partnership to hold investments in two medical device companies.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- ev3, LLC, a new investment partnership controlled by Warburg Pincus, the global private equity firm, announced that its holdings now include 100% of ev3, Inc., and approximately 70% of Micro...

Composition patent for Sinusol filed.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Advanced Plant Pharmaceuticals, Inc., (APPI) a company that utilizes whole plants through a proprietary (patent pending) manufacturing process to develop nutraceuticals and supplements, has announced...

Patent issued covering cremophor-free taxanes.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- American Pharmaceutical Partners, Inc., (APPX, APP) announced that U.S. Patent #6,506,405 was issued to American BioScience, Inc., (ABI), the privately held parent company of APP, and its inventors,...

Rights to Loestrin oral contraceptive obtained.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Barr Laboratories, Inc., (BRL) and Galen Holdings PLC announced that they have signed a letter of intent for Barr to acquire from Galen the exclusive rights in the United States and Canada for Loestrin...

Antidepressant, proton pump inhibitor lead first half 2003 in drug promotion.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Forest Laboratories, Inc.'s, Lexapro and TAP Pharmaceuticals, Inc.'s, Prevacid were the prescription drugs most heavily promoted to managed care pharmacy directors during the first 6 months of 2003,...

Driving market uptake through successful physician messaging.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Executives at pharmaceutical companies consider major conferences and peer-reviewed journals as the best channels for communicating clinical trial results to physicians, according to a just-released...

Drug-eluting stents improve outcomes in heart stent procedures.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- ECRI's technology assessment of published studies on the implantation of drug-eluting stents after angioplasty concluded that the rate of coronary artery restenosis (reblockage or renarrowing of the...

Study: Market research critical to blockbuster launches.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- In an increasingly competitive market, pharmaceutical companies invest more and more in market research to improve product positioning, according to a study from pharmaceutical research firm, Best...

AMA will provide electronic ethics alerts to physicians.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- The American Medical Association announced that it will provide free "ethics alerts" to physicians via ePocrates' DocAlert system, a messaging system for personal digital assistants (PDAs). These...

Two clinical milestones achieved for Vitaxin.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Applied Molecular Evolution, Inc., (AME, AMEV) announced that it has achieved two separate milestones as a result of the initiation of phase II clinical trials for Vitaxin in both cancer and rheumatoid...

Acquisition offers company methods to fight bioterrorism.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Nutra Pharma Corp. (NPHC) has signed a letter of intent to acquire 100% of the capital stock of Infectech Inc. (IFEC) in a cash and stock transaction, providing Nutra Pharma with patented technologies...

Assets of Physicians Nutraceutical Laboratories acquired.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Bio-One Corporation (BICO) has acquired the assets of Florida based Physicians Nutraceutical Laboratories, Inc., in a transaction that includes a combination of cash and a royalty agreement. ...

Genzyme completes tender offer.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Genzyme Corp. (GENZ) announced that, through a wholly owned subsidiary, it has completed its tender offer to acquire outstanding shares of SangStat Medical Corp. (SANG) for $22.50 per share. ...

Hillenbrand Industries plans to acquire the maker of The Vest.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Hillenbrand Industries, Inc., (HB) has signed a definitive agreement to acquire Advanced Respiratory, Inc., a privately held manufacturer and distributor of noninvasive airway clearance products and...

Imaging company to be acquired.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Atto Bioscience, Inc., announced that it has signed a definitive agreement to acquire Cytoprint, Inc., in a cash and stock transaction projected to close by October 31, 2003. Cytoprint, a privately...

Martek completes acquisition of South Carolina company.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Martek Biosciences Corp. (MATK) announced that it has completed its planned acquisition of certain of the assets and assumption of certain of the liabilities of FermPro Manufacturing, L.P., of...

Pain management company acquires assets of its distributor.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Advanced Neuromodulation Systems, Inc., (ANS, ANSI) announced that it has acquired certain assets of its exclusive distributor of pain management products for the Northwestern United States, Comedical,...

Peoples Genetics' technologies acquired for genetic analyses.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Beckman Coulter, Inc., (BEC) announced they have acquired the technologies of Peoples Genetics, Inc., (PGI) of Woburn, Massachusetts. The technologies are used for the comprehensive genetic analysis...

U.K. consumer dermatology business sold to Ferndale Pharmaceuticals.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Ecolab, Inc., announced that it has sold the consumer dermatology business of its Adams Healthcare subsidiary to Ferndale Pharmaceuticals, Ltd., in Leeds, United Kingdom. The annualized sales of...

Nanogen teams to develop infectious disease diagnostics.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Nanogen, Inc., (NGEN) and Prodesse, Inc., announced the signing of a collaboration agreement to develop automated, highly sensitive microarray-based products to detect a number of infectious disease...